Suscribirse

Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA) - 11/09/20

Doi : 10.1016/j.diabet.2019.10.005 
N.L. Weir a, B.T. Steffen a, W. Guan b, L.M. Johnson c, L. Djousse d, K.J. Mukamal e, M.Y. Tsai a,
a University of Minnesota, Department of Laboratory Medicine & Pathology, 312 Church St. SE Room 3-110, Minneapolis, MN 55455, USA 
b University of Minnesota, School of Public Health Biostatistics Division, Minneapolis, MN 55455, USA 
c University of Utah, Department of Pathology, Salt Lake City, UT 84108, USA 
d Brigham and Women's Hospital, Department of Medicine Division of Aging, Boston, MA 02115, USA 
e Beth Israel Deaconess Medical Center, General Medicine, Brookline, MA 02446, USA 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Aim

Determine whether plasma omega-7 vaccenic acid and palmitoleic acid levels are related to homeostasis model of insulin resistance scores and incident type II diabetes, and whether race/ethnicity modifies these associations.

Methods

Plasma phospholipid fatty acids were measured by gas chromatography with flame-ionization detection in Multi-Ethnic Study of Atherosclerosis participants. Linear regression determined associations of vaccenic acid and palmitoleic acid with log-transformed homeostasis model of insulin resistance scores (n=5689), and Cox regression determined associations with incident type II diabetes (n=5413, 660 cases). Race-interactions were tested.

Results

Adjusting for typical risk factors, higher levels of plasma vaccenic acid were found to be inversely associated with insulin resistance scores across all four race/ethnicities, and a significant race-interaction was observed between Hispanics and Caucasians (P for interaction=0.03). Vaccenic acid was related to 17%, 32%, and 39% lower risks of incident type II diabetes in Black, Hispanic, and Chinese American participants, respectively. Differences in associations between races were detected (P for interactions<0.05). By contrast, higher levels of plasma palmitoleic acid were related to greater insulin resistance scores in Blacks (P<0.001) and Hispanics (P<0.001); significant race-based differences between associations were detected (P for interactions<0.05). Palmitoleic acid was correspondingly related to a 21% greater risk of incident type II diabetes in Black individuals.

Conclusions

Results suggest that plasma vaccenic acid and palmitoleic acid are markers of metabolic health and dysfunction, respectively. Coupled with previous evidence and the significant race-interactions, our findings have implications for future studies of the race-based differences in omega-7 fatty acids and their regulation in the context of deteriorating metabolic health.

El texto completo de este artículo está disponible en PDF.

Keywords : HOMA, MESA, Omega-7, Plasma fatty acid, Race, Type 2 diabetes


Esquema


© 2019  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 46 - N° 4

P. 319-325 - septembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria
  • E. Cosson, E. Vicaut, D. Sandre-Banon, F. Gary, I. Pharisien, J.-J. Portal, C. Baudry, C. Cussac-Pillegand, D. Costeniuc, P. Valensi, L. Carbillon
| Artículo siguiente Artículo siguiente
  • Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes
  • A. Mantovani, A. Altomari, G. Lunardi, S. Bonapace, G. Lippi, F. Bonnet, G. Targher

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.